ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 729531 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 729531; 2) Community: the network communities that were significantly associated with the response to NSC 729531; 3) Molecule: the relationships between components within communities and NSC 729531; 4) MDR: the compounds that were significantly associated with the NSC 729531.

NSC Compound Enrichment Correlation
NSC 720299 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane 0.00415749398947839 0.34170113
NSC 737231 Null 0.00415749398947839 0.4105325
NSC 744063 Null 0.00415749398947839 0.45391931
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.00415749398947839 0.26726525
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0041872854493286 0.435791
NSC 18805 .gamma.-Thujaplicine 0.0041872854493286 0.38222477
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0041872854493286 0.21200264
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0041872854493286 0.10191635
NSC 42972 Null 0.0041872854493286 0.12202839
NSC 608329 Null 0.0041872854493286 0.11547685
Total:153  Current:16    [First] [Prev] [Next] [Last]